Compugen Ltd (CGEN)

• $1.69

  $1.73

  $1.69
  

  0.0%

  Downside

  Day's Volatility :2.31%

  Upside

  2.31%

  
• $0.53

  $3.03

  $1.69
  

  68.64%

  Downside

  52 Weeks Volatility :82.51%

  Upside

  44.23%

  

Returns

What analysts predicted

Upside of 195.86%

compugen is a leading drug discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology and oncology. the company utilizes a broad and continuously growing integrated infrastructure of proprietary scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biology capabilities for the in silico (by computer) prediction and selection of product candidates, which are then advanced in its pipeline program. the company's business model includes collaborations covering the further development and commercialization of product candidates at various stages from its pipeline program and various forms of research and discovery agreements, in both cases providing compugen with potential milestone payments and royalties on product sales or other forms of revenue sharing. compugen’s wholly-owned u.s. subsidiary located in south san francisco is developing monoclonal antib